Application Nr Approved Date Route Status External Links
ANDA076201 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Carefully Consider The Potential Benefits And Risks Of Diclofenac Sodium Extended Release Tablets, Usp And Other Treatment Options Before Deciding To Use Diclofenac Sodium Extended-Release Tablets. Use The Lowest Effective Dose For The Shortest Duration Consistent With Individual Patient Treatment Goals (See Warnings; Gastrointestinal Bleeding, Ulceration, And Perforation ) . Diclofenac Sodium Extended-Release Tablets Are Indicated: • For Relief Of The Signs And Symptoms Of Osteoarthritis • For Relief Of The Signs And Symptoms Of Rheumatoid Arthritis

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Diclofenac Sodium DICLOFENAC SODIUM ZINC1281

Comments